ATE300310T1 - Verfahren zur steigerung von hematopoietischen zellen - Google Patents

Verfahren zur steigerung von hematopoietischen zellen

Info

Publication number
ATE300310T1
ATE300310T1 AT96921229T AT96921229T ATE300310T1 AT E300310 T1 ATE300310 T1 AT E300310T1 AT 96921229 T AT96921229 T AT 96921229T AT 96921229 T AT96921229 T AT 96921229T AT E300310 T1 ATE300310 T1 AT E300310T1
Authority
AT
Austria
Prior art keywords
cells
methods
hematopoietic cells
donor
thrombopoietin
Prior art date
Application number
AT96921229T
Other languages
English (en)
Inventor
Willem E Fibbe
Angelika Grossmann
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE300310T1 publication Critical patent/ATE300310T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/196—Thrombopoietin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96921229T 1995-06-07 1996-05-29 Verfahren zur steigerung von hematopoietischen zellen ATE300310T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/482,212 US6013067A (en) 1995-06-07 1995-06-07 Methods for increasing hematopoietic cells
PCT/US1996/007880 WO1996040218A1 (en) 1995-06-07 1996-05-29 Methods for increasing hematopoietic cells

Publications (1)

Publication Number Publication Date
ATE300310T1 true ATE300310T1 (de) 2005-08-15

Family

ID=23915172

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921229T ATE300310T1 (de) 1995-06-07 1996-05-29 Verfahren zur steigerung von hematopoietischen zellen

Country Status (10)

Country Link
US (1) US6013067A (de)
EP (1) EP0831888B1 (de)
JP (1) JP3058353B2 (de)
KR (1) KR19990022420A (de)
CN (1) CN1190348A (de)
AT (1) ATE300310T1 (de)
AU (1) AU693032B2 (de)
CA (1) CA2223046A1 (de)
DE (1) DE69634982T2 (de)
WO (1) WO1996040218A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879673A (en) * 1996-01-25 1999-03-09 Genentech, Inc. Administration of thrombopoietin on a single day only
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
AU2006201129B2 (en) * 1997-05-21 2008-03-13 Genentech, Inc. Novel administration of thrombopoietin
US8313742B2 (en) * 2002-03-29 2012-11-20 Depuy Acromed, Inc. Cell-containing bone graft material
WO2003101308A1 (en) 2002-06-04 2003-12-11 Office Of Technology Licensing Stanford University Device and method for rapid aspiration and collection of body tissue from within an enclosed body space
US20040028661A1 (en) * 2002-08-07 2004-02-12 Bartelmez Stephen H. Expansion of cells using thrombopoietin and anti-transforming growth factor-beta
MXPA05003057A (es) 2002-09-18 2006-04-18 Johnson & Johnson Metodos para aumentar la produccion de celulas madre hematopoyeticas y plaquetas.
AU2003271175A1 (en) 2002-10-11 2004-05-04 Masahiro Abe Cell death-inducing agent
TW200530269A (en) 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Anti-Mpl antibodies
ES2538305T3 (es) * 2004-10-25 2015-06-18 Cellerant Therapeutics, Inc. Métodos para expandir poblaciones de células mieloides y usos de las mismas
EP1870458B1 (de) 2005-03-31 2018-05-09 Chugai Seiyaku Kabushiki Kaisha sc(Fv)2-STRUKTURISOMERE
CN101262885B (zh) 2005-06-10 2015-04-01 中外制药株式会社 含有sc(Fv)2的药物组合物
US20090028854A1 (en) * 2005-06-10 2009-01-29 Chugai Seiyaku Kabushiki Kaisha sc(Fv)2 SITE-DIRECTED MUTANT
CA2610987C (en) * 2005-06-10 2013-09-10 Chugai Seiyaku Kabushiki Kaisha Stabilizer for protein preparation comprising meglumine and use thereof
JPWO2007145227A1 (ja) * 2006-06-14 2009-11-05 中外製薬株式会社 造血幹細胞増加促進剤
EP2351599A4 (de) 2008-11-14 2013-05-08 Dnavec Corp Verfahren zur herstellung dendritischer zellen
US9187728B2 (en) 2010-06-14 2015-11-17 Nissan Chemical Industries, Ltd. Method for producing hematopoietic stem cells
CA3010792A1 (en) 2016-01-14 2017-07-20 DePuy Synthes Products, Inc. Composition and methods for cryopreservation of hutc
EP3397172B1 (de) 2016-02-01 2025-10-01 Regenmed Systems, Inc. Kanüle für gewebedisruption
AU2017259271B2 (en) 2016-05-02 2022-03-17 Kellanova System and method for applying a fastening material to a substrate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894440A (en) * 1986-09-17 1990-01-16 Massachusetts Institute Of Technology Method of isolating megakaryocyte stimulatory factor
US4946437A (en) * 1988-12-02 1990-08-07 Bar-Ilan University Method for the stimulation of bone marrow cells
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
US5571686A (en) * 1994-04-14 1996-11-05 Massachusetts Institute Of Technology Method of using megapoietin for prolonging the survival & viability of platlets

Also Published As

Publication number Publication date
EP0831888A1 (de) 1998-04-01
CN1190348A (zh) 1998-08-12
JP3058353B2 (ja) 2000-07-04
CA2223046A1 (en) 1996-12-19
DE69634982T2 (de) 2006-04-27
WO1996040218A1 (en) 1996-12-19
US6013067A (en) 2000-01-11
JPH10510842A (ja) 1998-10-20
MX9709244A (es) 1998-03-31
EP0831888B1 (de) 2005-07-27
AU693032B2 (en) 1998-06-18
DE69634982D1 (de) 2005-09-01
AU6250096A (en) 1996-12-30
KR19990022420A (ko) 1999-03-25

Similar Documents

Publication Publication Date Title
ATE300310T1 (de) Verfahren zur steigerung von hematopoietischen zellen
Jager et al. Bone marrow concentrate: a novel strategy for bone defect treatment
DE69837491D1 (de) Menschliche mesenchymale stammzellen aus peripherem blut
DK1294414T3 (da) Præparat og fremgangsmåde til heling og regenerering af brusk og andre væv
WO2007024441A2 (en) Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
NO992569D0 (no) FremgangsmÕter for Õ hindre podingsforkastelse i transplantasjon og for fremstilling av en universell genterapi vertcelle ved Õ anvende lymfocytt aktivering (LAG-3)
EP1135531A4 (de) Methoden zur introduktion heterologer zellen in fische
US20090016997A1 (en) Autologous/allogeneic human DNA grafting, anti-and reverse aging stem cell, and bone marrow compositions/methods
DE69624937D1 (de) Verfahren zur verminderung der strahlentherapie oder der radiomimetischen chemotherapie bei der transplantation von hematopoietischen, pluripotenten zellen
US11760976B2 (en) Stem cells and decellularization of tissue matrix from cord tissue
US20160120909A1 (en) Compositions And Methods For The Treatment Of Tinnitus
EP2268293A2 (de) Stammzellenzusammensetzung zur auslösung von transplantattoleranz
Watanabe et al. Autologous and allogeneic transplantation with peripheral blood CD34+ cells: a pediatric experience
Hung Effects of hypoxic culture on bone marrow mesenchymal stem cells: from bench to bedside
Weinberg Hematopoietic progenitor cell products derived from bone marrow and peripheral blood
WO2005105169A1 (ja) 脂肪組織由来幹細胞から骨髄を形成するための組成物およびその方法
Henon Peripheral blood stem cell transplantation: critical review
Kevy et al. Point of care concentration of bone marrow
Chen et al. Specially modified stromal and immune microenvironment in injected bone marrow following intrabone transplantation facilitates allogeneic hematopoietic stem cell engraftment
CN115322962A (zh) 基于细胞分泌物筛选源细胞的方法、源细胞、细胞库及产品
Pigneux et al. Autologous peripheral blood stem cell transplantation for chronic myelocytic leukaemia, using unmanipulated grafts
ATE263833T1 (de) Verwendung von dendritischen zellen-depletierten zusammensetzungen zur verbesserung der transplantation von allogenen hämatopoietischen zellen
Antonenas et al. Optimum temperature for maintaining the viability of CD34+ cells during storage and transport of fresh haematopoietic progenitor cells
Yankelevich et al. The role of cytotoxic T cell antigen-2 (CTLA2) in mouse hematopoietic stem cell (HSC) transplant engraftment and reconstitution examined by lentiviral vector transduction
Peközer et al. Bone tissue engineering using STRO-1 positive porcine dental germ stem cells encapsulated in a poly-ethylene glycol based hydrogel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0831888

Country of ref document: EP

REN Ceased due to non-payment of the annual fee